David E. Elder

5.2k total citations · 1 hit paper
78 papers, 3.4k citations indexed

About

David E. Elder is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, David E. Elder has authored 78 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 22 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in David E. Elder's work include Cutaneous Melanoma Detection and Management (59 papers), Melanoma and MAPK Pathways (16 papers) and Cancer Genomics and Diagnostics (12 papers). David E. Elder is often cited by papers focused on Cutaneous Melanoma Detection and Management (59 papers), Melanoma and MAPK Pathways (16 papers) and Cancer Genomics and Diagnostics (12 papers). David E. Elder collaborates with scholars based in United States, France and Australia. David E. Elder's co-authors include Richard A. Scolyer, Daniela Massi, Wallace H. Clark, DuPont Guerry, Rein Willemze, Boris C. Bastian, Allan C. Halpern, Raymond L. Barnhill, Ian A. Cree and Meenhard Herlyn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

David E. Elder

76 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway

2020 304 citations David E. Elder, Daniela Massi et al. profile →

Peers

Countries citing papers authored by David E. Elder

Since Specialization

Citations

This map shows the geographic impact of David E. Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Elder more than expected).

Fields of papers citing papers by David E. Elder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Elder. The network helps show where David E. Elder may publish in the future.

Co-authorship network of co-authors of David E. Elder

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Elder. A scholar is included among the top collaborators of David E. Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Elder. David E. Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival 2024 ·Clinical Cancer Research ·(unknown), Tara C. Mitchell, (unknown), (unknown), (unknown), David E. Elder, (unknown), Phyllis A. Gimotty, Alexander C. Huang, Ravi K. Amaravadi, Lynn M. Schuchter, (unknown), John T. Miura, Giorgos C. Karakousis, Xiaowei Xu	1
2	Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study 2024 ·BMJ Open ·(unknown), Brooke Nickel, (unknown), David E. Elder, Peter M. Ferguson, Richard A. Scolyer, (unknown), Raymond L. Barnhill, Adewole S. Adamson, (unknown), Jon Emery, Lisa Parker, Donald E. Low, (unknown), (unknown), (unknown), Sharon Lewis, (unknown), Katy Bell	2
3	Melanoma Diagnosis in the Mihm Era—And Beyond 2024 ·Journal of Cutaneous Pathology ·David E. Elder	2
4	Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions 2023 ·JAMA Dermatology ·Kathleen F. Kerr, David E. Elder, Michael W. Piepkorn, Stevan R. Knezevich, Megan Eguchi, Hannah Shucard, Lisa M. Reisch, Joann G. Elmore, Raymond L. Barnhill	5
5	Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very‐low melanoma mortality 2022 ·Cancer ·Megan Eguchi, David E. Elder, Raymond L. Barnhill, Michael W. Piepkorn, Stevan R. Knezevich, Joann G. Elmore, Kathleen F. Kerr	15
6	Dermatopathologist Perceptions of Overdiagnosis of Melanocytic Skin Lesions and Association With Diagnostic Behaviors 2022 ·JAMA Dermatology ·Kathleen F. Kerr, Megan Eguchi, Michael W. Piepkorn, (unknown), Lisa M. Reisch, Hannah Shucard, Stevan R. Knezevich, Raymond L. Barnhill, David E. Elder, Joann G. Elmore	9
7	Diagnostic error, uncertainty, and overdiagnosis in melanoma 2022 ·Pathology ·David E. Elder, Megan Eguchi, Raymond L. Barnhill, Kathleen F. Kerr, Stevan R. Knezevich, Michael W. Piepkorn, Lisa M. Reisch, Joann G. Elmore	11
8	Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16 2020 ·American Journal of Ophthalmology ·Tatyana Milman, Qiang Zhang, (unknown), David E. Elder, Sara E. Lally, Jerry A. Shields, Rose A. Hamershock, Kareem Sioufi, Carol L. Shields, Ralph C. Eagle	11
9	WHO classification of skin tumours 2018 ·David E. Elder, Daniela Massi, Richard A. Scolyer, Rein Willemze	274
10	Histologic features of melanoma associated with CDKN2A genotype 2015 ·Journal of the American Academy of Dermatology ·Michael R. Sargen, Peter A. Kanetsky, Julia Newton‐Bishop, Nicholas K. Hayward, Graham J. Mann, Nelleke A. Gruis, Margaret A. Tucker, Alisa M. Goldstein, Giovanna Bianchi‐Scarrà, Susana Puig, David E. Elder	18
11	Outcomes of Atypical Spitz Tumors With Chromosomal Copy Number Aberrations and Conventional Melanomas in Children 2013 ·The American Journal of Surgical Pathology ·Pedram Gerami, Chelsea Cooper, Shirin Bajaj, Annette Wagner, Douglas R. Fullen, Klaus J. Busam, Richard A. Scolyer, Xiaowei Xu, David E. Elder, Ronnie M. Abraham, Víctor G. Prieto, Joan Guitart, Ping Liu, Ekaterina Pestova, Raymond L. Barnhill	65
12	Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number Aberrations 2013 ·The American Journal of Surgical Pathology ·Pedram Gerami, Richard A. Scolyer, Xiaowei Xu, David E. Elder, Ronnie M. Abraham, Douglas R. Fullen, Víctor G. Prieto, Philip E. LeBoit, Raymond L. Barnhill, Chelsea Cooper, Pedram Yazdan, Joan Guitart, Ping Liu, Ekaterina Pestova, Klaus J. Busam	116
13	Sunbeds and sunlamps: who used them and their risk for melanoma 2011 ·Pigment Cell & Melanoma Research ·Thomas R. Fears, Richard W. Sagebiel, Allan C. Halpern, David E. Elder, Elizabeth A. Holly, DuPont Guerry, Margaret A. Tucker	25
14	Precursors to melanoma and their mimics: nevi of special sites 2006 ·Modern Pathology ·David E. Elder	113
15	Expression of Melan-A and Ki-67 in Desmoplastic Melanoma and Desmoplastic Nevi 2004 ·American Journal of Dermatopathology ·(unknown), Paul J. Zhang, Theresa L. Pasha, Rosalie Elenitsas, Hong Wu, Michael E. Ming, David E. Elder, Xiaowei Xu	48
16	Familial cutaneous melanoma and two-mutational-event modeling 1993 ·Cancer ·Daniella Duke, Javier S. Castresana, (unknown), (unknown), Arthur J. Sober, William Carey, David E. Elder, Raymond L. Barnhill	7
17	A Cohort Study of Melanoma in Patients with Dysplastic Nevi. 1993 ·Journal of Investigative Dermatology ·Allan C. Halpern, DuPont Guerry, David E. Elder, Bruce J. Trock, Marie Synnestvedt	8
18	Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the world health organization melanoma programme 1991 ·Human Pathology ·Claudio Clemente, Alistair J. Cochran, David E. Elder, Arnold Levene, Rona M. MacKie, Martín C. Mihm, Franco Rilke, Natale Cascinelli, Thomas B. Fitzpatrick, Arthur J. Sober	111
19	Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease 1990 ·Journal of the American Academy of Dermatology ·(unknown), Wallace H. Clark, DuPont Guerry, Allan C. Halpern, C. Jean Thompson, David E. Elder	153
20	Antigens Associated with Tumor Progression in Melanocytic Neoplasia 1990 ·Pigment Cell Research ·David E. Elder, Meenhard Herlyn	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact